EMR vs VRTX · P/E 34, rev $4.86B vs P/E 30, rev $3.33B
Emerson Electric Company (EMR) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
EMR currently screens at market cap $83.45B and trailing P/E 34.5. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the EMR and VRTX stock pages for the full models.
Not investment advice.